United States · FDA National Drug Code directory

LUMISIGHT

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
82292-040_8a6aec36-4e75-4cd0-a250-cb126128bbd4
Product NDC
82292-040
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Composition / generic term
Pegulicianine
Labeler
Lumicell, Inc.
Marketing category
NDA
Marketing start / end (source format)
20240417
Source listing expiry
20271231

Source-listed ingredients

  • PEGULICIANINE — 10 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 VIAL in 1 CARTON (82292-040-10) / 3.9 mL in 1 VIAL (82292-040-01) · 82292-040-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
LUMISIGHT — United States | Molindra Medicines